Skip to content
BidBenchmark

Contract award

LOVELACE BIOMEDICAL RESEARCH INSTITUTE

EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.
PIID
75N95021F00002
Award key
CONT_AWD_75N95021F00002_7529_75N95019D00012_7529
Recipient UEI
MBT9RXJJ7428
Parent award
CONT_IDV_75N95019D00012_7529
Source as of
Current award value
$452,9313
Obligated to date
$452,9312
Potential with options
$452,9313
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Albuquerque, New Mexico
Set-aside
None
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition
Period of performance
Sep 29, 2021May 31, 2026Through May 31, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 28, 2021Initial award$623,883.00$452,930.99
P00001Aug 16, 2023B$0.00$452,930.99
P00002May 7, 2025F-$256,960.00$452,930.99
P00003May 29, 2026B$86,007.99$452,930.99

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e
contractor_idUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e
current_award_valueUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e
naics_codeUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e
potential_award_valueUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e
psc_codeUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e
total_obligatedUSAspending.govAug 15, 2026usaspending_contract_csv@2026.08.23048443c242e

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 4 transaction records parsed from USAspending.gov, retrieved Aug 15, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N95021F00002 — LOVELACE BIOMEDICAL RESEARCH INSTITUTE · BidBenchmark